<DOC>
	<DOCNO>NCT02359344</DOCNO>
	<brief_summary>A randomized , double-blind , placebo control , two period crossover study investigate pharmacokinetics , tolerability cognitive effect 8 day dose CNV1014802 healthy young versus elderly male female subject . Treatment period separate 13 day . The primary outcome measure pharmacokinetics ( PK ) tolerability .</brief_summary>
	<brief_title>PK &amp; Tolerability CNV1014802 Young Elderly Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<criteria>Key Healthy male female 18 year use acceptable method contraception Key Positive prestudy HIV , Hepatitis B surface antigen positive Hepatitis C antibody History evidence alcohol drug abuse Pregnant lactating female Participation clinical trial within 3 month current study exposure four new chemical entity within 12 month . Use prohibit concomitant medication History presence clinically significant abnormality vital sign / ECG / laboratory test , medical psychiatric condition , , opinion Investigator may interfere study procedure compromise subject safety . Relevant history suicide attempt suicidal behavior</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>